1
Clinical Trials associated with GSK-3862995BA Two-part Phase 1 Randomized, Double-blind, Placebo-controlled Study to Investigate Safety, Tolerability, Immunogenicity, Pharmacokinetics and Pharmacodynamics of GSK3862995B Following Single Ascending Doses in Healthy Participants and Repeat Doses in Participants With Chronic Obstructive Pulmonary Disease
The primary objective of the study is to investigate the safety and tolerability of ascending doses of GSK3862995B following single dose in healthy participants and repeat doses in participants with Chronic obstructive pulmonary disease (COPD).
100 Clinical Results associated with GSK-3862995B
100 Translational Medicine associated with GSK-3862995B
100 Patents (Medical) associated with GSK-3862995B
100 Deals associated with GSK-3862995B